Helix BioMedix, Inc. (HXBM.OB) Reports Third Quarter Results
Helix BioMedix, Inc. announced yesterday financial results for the Company’s third quarter 2010 ended September 30, 2010. Revenue for the third quarter of 2010 was approximately $94,000, compared to approximately $98,000 for the third quarter of 2009 and approximately $330,000 for the second quarter of 2010. For the first nine months of 2010, revenue was approximately $494,000, compared to approximately $324,000 for the first nine months of 2009. The 53 percent increase in revenue through the first nine months of 2010 reflects a significant increase in licensing revenue and growth in international consumer product sales through Helix BioMedix, Inc.’s new…